Skip to content

Clinical trial of thoracoamniotic shunting for fetal pleural effusion

Clinical trial of thoracoamniotic shunting for fetal pleural effusion - Fetal PE shunt trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000001095
Enrollment
20
Registered
2008-03-28
Start date
2008-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal pleural effusion

Interventions

A shunt catheter (double bascket) is placed percutaneously between the fetal thorax and the amniotic fluid space under ultrasound guidance. For bilateral pleural effusions, shunt catheters are placed

Sponsors

Japan Fetal Therapy Group (Fetusjapan)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Between 18 weeks and 33 weeks 6 days gestation 2) Singletone pregnancy 3) Massive unilateral/bilateral pleural effusion of the fetus detected ultrasound within four days 4) Reaccumulation of fetal pleural effusion after thoracocentesis in seven days 5) Written consents to the trial from the mother and her husband

Exclusion criteria

Exclusion criteria: 1) Following ultrasound findings of the fetus detected within four days a. Anomaly except bronchopulmonary sequestration, cleft lip and palate, minor anomaly of fingers b. Tachycardia more than 200 bpm c. Bradycardia below 60 bpm d. Brain calcification e. Fetal anemia suspected by increased peak flow velocity of middle cerebral artery 2) Prior treatment for fetal pleural effusion except thoracocentesis 3) Positive indirect Coombs test 4) Chromosomal abnormality except Down syndrome 5) Mirror syndrome 6) Pregnancy induced hypertension 7) Genital bleeding 8) Short cervical length (<10mm)

Design outcomes

Primary

MeasureTime frame
Infant survival over 28 days of age

Secondary

MeasureTime frame
Reversal of hydrops, adverse events, complications of shunting

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026